Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market
Holding ENSC?
Track your performance easily

Ensysce Biosciences (ENSC) Income Statement

224 Followers

Ensysce Biosciences Income Statement

Last quarter (Q2 2024), Ensysce Biosciences's total revenue was $181.80K, a decrease of -62.93% from the same quarter last year. In Q2, Ensysce Biosciences's net income was $-1.97M. See Ensysce Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
$ 1.44M$ 2.23M$ 2.52M$ 2.73M
Cost of Revenue
----
Gross Profit
$ 1.44M$ 2.23M$ 2.52M$ 2.73M
Operating Expense
$ 6.80M$ 10.72M$ 26.75M$ 23.40M
Operating Income
$ -9.66M$ -10.72M$ -24.22M$ -20.67M
Net Non Operating Interest Income Expense
$ -1.60M$ -353.94K$ -109.53K$ -8.84M
Other Income Expense
$ 6.82K$ 445.86K$ -123.94K$ 436.67K
Pretax Income
$ -6.97M$ -10.63M$ -25.12M$ -29.95M
Tax Provision
$ -77.24K$ -77.24K$ -175.16K$ -1.60K
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -11.28M$ -10.63M$ -25.09M$ -29.89M
Basic EPS
$ -2.97$ -4.69$ -139.44$ -17.76
Diluted EPS
$ -2.97$ -4.69$ -139.44$ -17.76
Basic Average Shares
$ 20.24M$ 2.26M$ 179.93K$ 1.68M
Diluted Average Shares
$ 20.24M$ 2.26M$ 179.93K$ 1.68M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 6.80M$ 10.72M$ 26.75M$ 23.40M
Net Income From Continuing And Discontinued Operation
$ -11.28M$ -10.61M$ -25.09M$ -29.89M
Normalized Income
$ -7.64M$ -10.72M$ -25.30M-
Interest Expense
----
EBIT
$ -5.39M$ -10.27M$ -25.01M$ -28.65M
EBITDA
$ -4.19M$ -10.27M$ -25.01M$ -28.65M
Currency in USD

Ensysce Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis